Virios Therapeutics Inc. is a development-stage biotechnology company focused on advancing antiviral therapies to treat debilitating chronic diseases such as fibromyalgia (FM). The Company’s lead development candidate is IMC-1 which is a fixed dose... Read more
SeekingAlpha
MarketWatch
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.